Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Reports Revenue Hike, Increased Losses for Q2

NEW YORK, July 15-Cepheid today reported increased losses and a steep hike in revenues for the second quarter of 2002. 


For the three months ended June 30, 2002, revenues were $3.2 million, up from 2 million for the same quarter in 2001. Net losses were $5.5 million (21 cents per share) for the quarter, up from $4.1 million (16 cents per share) from the same quarter last year.


The company attributed its increased losses to R&D spending for its GeneXpert system. Cepheid opened a new California manufacturing center in June, and hopes to have that system in production by the end of the year.


Cepheid is being considered for a  contract by the United States Postal Service to install DNA-detection systems in its mail sorting facilities nationwide, an arrangement that could bring the company $25 million to $40 million in 2003, company representatives said.


The USPS plans to award the contract by the end of September 2002.


Cepheid executives said in a conference call that the company's directors planned to expand international sales. The company also announced an agreement with MedProbe to act as Cepheid's exclusive distributor in Norway, Sweden, Denmark, Finland and Iceland.


Cepheid said it had about $16 million in the bank. "We're in pretty good shape," said CEO John Bishop.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.